Á lódáil...

Simvastatin Reduces Circulating Plasminogen Activator Inhibitor 1 Activity in Volunteers with the Metabolic Syndrome

BACKGROUND: The Metabolic Syndrome (MS) confers an increased risk for diabetes and cardiovascular disease. We previously showed that simvastatin has concomitant benefits in reducing low-density lipoprotein (LDL)–cholesterol and inflammation in MS subjects. The levels of plasminogen activator inhibit...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Wang, Long, Rockwood, Jason, Zak, Danielle, Devaraj, Sridevi, Jialal, Ishwarlal
Formáid: Artigo
Teanga:Inglês
Foilsithe: Mary Ann Liebert, Inc. 2008
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2692921/
https://ncbi.nlm.nih.gov/pubmed/18484901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/met.2008.0012
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!